Iradimed (IRMD) Asset Writedowns and Impairment (2014 - 2026)
Iradimed (IRMD) posted quarterly Asset Writedowns and Impairment of $13000.0 for Q2 2026, up 160.0% year-over-year from $5000.0 in Q2 2025, and down 67.5% on a QoQ basis from $40000.0 in Q1 2026.
Iradimed (IRMD) Asset Writedowns and Impairment (2014 - 2026) Analysis & Trends
Iradimed has reported Asset Writedowns and Impairment for 13 years, with the latest figure at $13000.0 in Q2 2026.
- Asset Writedowns and Impairment for Q2 2026 came in at $13000.0, up 160.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $2000.0 (up 100.86% YoY), and the FY2025 annual result was -$84000.0, up 11.58% from the prior year.
- Asset Writedowns and Impairment slipped to $13000.0 in Q2 2026, from $40000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $180788.0 in Q1 2023 and troughed at -$297140.0 in Q4 2024.
- A 5-year average of $10283.6 and a median of $12627.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- The widest annual swing landed in 2022, when Asset Writedowns and Impairment surged 2886.53%; it then tumbled 2463.54% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $46649.0 in 2022, then plunged by 124.85% to -$11591.0 in 2023, then tumbled by 2463.54% to -$297140.0 in 2024, then surged by 99.71% to -$875.0 in 2025, then soared by 1585.71% to $13000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $13000.0 in Q2 2026, $40000.0 in Q1 2026, and -$875.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Jun 30, 2026 | 13,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 130,125.00 |
| Dec 31, 2025 | 130,125.00 |
| Sep 30, 2025 | -50,236.00 |
| Sep 30, 2025 | -50,236.00 |
| Jun 30, 2025 | -17,889.00 |
| Jun 30, 2025 | -17,889.00 |
| Mar 31, 2025 | -15,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 179,398.00 |
| Dec 31, 2024 | 179,398.00 |
| Sep 30, 2024 | -109,925.00 |
| Sep 30, 2024 | -109,925.00 |
| Jun 30, 2024 | -20,474.00 |
| Jun 30, 2024 | -20,474.00 |
| Mar 31, 2024 | 39,001.00 |
| Mar 31, 2024 | 39,001.00 |